Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Bartolo Colon

Quick Hits: Diaz, Peavy, Colon, Francoeur

By | at

Major League Baseball has ruled that Cuban shortstop Aledmys Diaz is ineligible to sign until February 2014, Ben Badler of Baseball America reports. Diaz had claimed to be born in January 1990, which would make him 23 and would mean MLB teams wouldn't be restricted by their international bonus pools in their attempts to sign him. Earlier media reports indicate that he is actually 22. A 22-year-old Cuban player would still have to sign under the bonus pool system. Ten teams were reported to have interest in Diaz. Here are more notes from around the Majors.

  • The White Sox's Jake Peavy says he wanted to ask the team if he could pitch for the big league club on Sunday, though he would have been denied, Mark Gonzales of the Chicago Tribune reports via Twitter. Peavy, who's been sidelined with a rib injury, will join the Sox's Double-A club on Wednesday if he's still feeling good at that time, Gonzales says. If he's healthy, Peavy could be a trade chip at the July 31 deadline.
  • Bartolo Colon is defying the odds yet again this season with the Athletics, Tyler Kepner of the New York Times writes. Colon currently has a 2.69 ERA with 4.9 K/9 and 1.1 BB/9 in 120 1/3 innings despite his age (40) and the fact that he was suspended last season for testing positive for testosterone. Common sense suggested that, without the use of PEDs, Colon couldn't keep pitching well, but the A's took a chance on Colon, signing him for $3MM plus bonuses. "Our organization thought he would be very similar based on what they saw in winter ball," says A's manager Bob Melvin. "He was throwing with the same velocity he does right now, the same movement. It was an easy sign for us and we did it very quickly, based on what everybody thought he would be like, and certainly he’s been that and more."
  • The Giants' signing of Jeff Francoeur is a "lightning-in-a-bottle play," Andrew Baggarly of CSNBayArea.com writes. Baggarly compares the acquisition to the Giants' May 2010 signing of Pat Burrell, who had been cast off by the Rays. Baggarly also notes that Francoeur and Kensuke Tanaka, who is making his big-league debut while starting in left field Tuesday night, will mean less playing time for Andres Torres.

Aaron Steen contributed to this post.

MLB Preparing To Suspend At Least 20 Players In Biogenesis Scandal

By | at

9:46pm: Besides Braun and Rodriguez, "other major, major names" are also involved in the Biogenesis case, a source tells Bob Klapsich of the Bergen Record (Twitter link).

6:56pm: Major League Baseball is planning to suspend at least 20 players connected to Biogenesis, the Miami clinic under investigation for supplying performance-enhancing drugs, reports T.J. Quinn, Pedro Gomez and Mike Fish of ESPN's Outside The Lines.  Biogenesis founder Tony Bosch has agreed to cooperate with the investigation and begin naming players, with suspensions possibly following within two weeks.

The list of possible suspensions includes Alex Rodriguez, Ryan Braun, Melky Cabrera, Nelson Cruz, Bartolo Colon, Yasmani Grandal, Francisco Cervelli, Jesus Montero, Jhonny Peralta, Cesar Puello, Fernando Martinez, Everth Cabrera, Fautino de los Santos and Jordan Norberto, plus others who are named in documents that the ESPN team haven't had access to, or are known under code names.

MLB officials have also investigated a possible connection between Biogenesis and Yankees second baseman Robinson Cano, as the spokeswoman for Cano's foundation (Sonia Cruz) has had her name appear in some clinic documents.  Nationals southpaw Gio Gonzalez isn't expected to face suspension for his connection to Biogenesis since the products he obtained from the clinic weren't banned.

The league could look for a 100-game suspension (the penalty for second-time PED offenders) for Rodriguez, Braun and other first-time offenders since both the connection to Biogenesis and previous denials to MLB officials would serve as seperate offenses.  It is unknown how MLB would deal with players like Cabrera or Colon who already have PED suspensions on their record, though these players probably wouldn't face a lifetime ban as three-time offenders — their prior suspensions would likely count as their so-called "first strike," with this next violation putting them in line for 100-game suspensions as well.

Quinn/Gomez/Fish report that, as expected, the accused players will challenge any possible suspensions and it could be difficult for the league to obtain corroborating evidence in the appeals process beyond Bosch's testimony.

Quick Hits: Cardinals, Braves, Starting Pitching Market

By | at

With one-fourth of the season in the books, let's have a look around some injury situations and how they might impact the developing trade market.

  • The Cardinals and Yankees provide an interesting case study as we enter the second quarter of the season. Both have excellent records and lead their division. Both have sizeable payrolls as well as large portions of those payrolls sitting idle on the DL. Both have had to insert players onto their active roster that they did not anticipate. But, as Derrick Goold of the St. Louis Post-Dispatch well explains, the source of those substitute bodies has been drastically different. While the Yankees spent well over $20MM to bring in players like Lyle Overbay, Kevin Youkilis, Travis Hafner, and Vernon Wells — all of whom are 34 or older — the Cards reached into their minor league system. Remarkably, St. Louis has plugged all of its holes with players making league minimum, including young pitchers John Gast, Shelby Miller, and Seth Maness.
  • The Goold piece also includes some valuable insight from GM John Mozeliak. According to Mozeliak, amongst the team's Double-A and Triple-A rosters, "there is almost at any one position, if we needed help at the big leagues, someone we could call on from there." He acknowledges that such cheap, youthful depth cannot always be achieved, and says the team is prepared to pursue other markets as necessary. "I don't want us to go down the path where we feel like we've created this functional model and don't utilize a really robust pro scouting model that makes sure we understand the trade market and understand the free agent market. We can't be scared of those." Yet, by looking internally first, the team has managed to retain salary flexibility to add outside impact down the line. "This organization's way now of staying healthy is not being tied to those outside markets to fill needs," says Mozeliak. "Having some young players step up like they are now gives us additional flexibility when we're going to need it."
  • The Cards' internal depth will once again be put to use with starter Jaime Garcia now staring at a strong possibility of season-ending shoulder surgery, writes Goold. Even with fellow starter Jake Westbrook also stuck on the DL, the team has multiple options among its current relief corps and Triple-A rotation that make a look outside the organization unlikely. Of course, it remains to be seen whether Garcia's replacement(s) can match his strong start to the year. He had thrown 55 1/3 innings of 3.58 ERA baseball to open the season. Veteran starter Chris Carpenter is increasingly shaping up as a viable mid-season option for the club. But any setback in his surprising recovery, or hiccups among the team's young hurlers, could lead St. Louis to consider eventually utilizing some of its salary reserves and young minor league depth in a trade.
  • The Braves are another National League contender dealing with injured arms. As Matt Snyder of CBSSports.com's Matt Snyder writes, Eric O'Flaherty appears likely to join fellow setup man Jonny Venters as a season-ending Tommy John patient. While the team seems likely to utilize internal options to fill in for the present, the loss of its two late-inning lefties leaves the team with just one southpaw in the pen, Luis Avilan. Ultimately, then, Atlanta could be forced to explore the trade market to re-establish its depth as the season wears on.
  • Teams shopping for starters at the trade deadline appear likely to find a limited supply of attractive arms, says ESPN.com's Buster Olney (Insider subscription required). Two Cubs pitchers headline the developing market, with Scott Feldman shaping up as the surprise top option at the moment. (Matt Garza, of course, will begin his potential audition on Tuesday.) In addition to several other well-documented trade candidates in Ricky Nolasco of the Marlins and the Astros' Bud Norris and Lucas Harrell, Olney pegs the Padres' Jason Marquis and Edinson Volquez as likely available. Meanwhile, Bartolo Colon of the Athletics and Cliff Lee of the Phillies could also be dealt, writes Olney, with the A's having other internal options and the Phils still weighing how to proceed with their excellent (but expensive) 35-year-old co-ace.

Gio, Cruz, Rodriguez, Cabrera Linked To PED Clinic

By | at

Gio Gonzalez and Nelson Cruz are among the MLB stars who have been linked to a supplier of performance enhancing drugs in a report from Tim Elfrink of the Miami New Times. A Miami-based clinic sold PEDs to athletes from various sports, according to the report. The names of Cruz, Gonzalez, Alex Rodriguez, Melky Cabrera and Bartolo Colon were found in the records at Biogenesis, an anti-aging clinic located near the University of Miami.

Gonzalez's name appears five times in the notebooks of Anthony Bosch, the clinic's chief. Cruz purchased $4,000 of product, according to the report. Rodriguez's name appears throughout the clinic's files, while Cabrera's name appears 14 times and Colon’s name also comes up.

Gonzalez has considerable security after agreeing to a five-year, $42MM contract with the Nationals last offseason. He'll earn $6.25MM in 2013 and remains under contract through 2016. Cruz will earn $10.5MM this year then hit free agency following the 2013 season. Cabrera, 28, signed a two-year, $16MM contract with the Blue Jays after serving a PED-related suspension at the end of the 2012 season. Colon, who has also served a PED-related suspension, signed a one-year, $3MM deal with the Athletics this offseason.

Rodriguez could face a suspension, Bob Nightengale of USA Today reports. However, don't expect the Yankees to be able to void the third baseman's contract. As Yahoo's Jeff Passan reports, the Yankees weren't able to void the deal after he admitted to using performance enhancing drugs for the first time (Twitter link). Rodriguez, who will miss much of the 2013 season recovering from a hip operation, has $114MM remaining on his contract with the Yankees.

Rodriguez and Gonzalez have both issued statements denying the allegations.

Athletics Sign Bartolo Colon

By | at

SUNDAY: The incentives in Colon's contract include provisions should he pitch in relief, according to the San Francisco Chronicle's Susan Slusser. Moving Colon to the bullpen would allow the A's to use other relievers as trade bait, opines Slusser.  

SATURDAY 9:37pm: Joe Stiglich of The Bay Area News Group reports (on Twitter) that the deal could be worth more than $5MM if Colon hits all of his incentives.

4:15pm: Colon's deal has a base salary of $3MM with a good incentives package, a source tells Susan Slusser of the San Francisco Chronicle (via Twitter).

3:20pm: The A’s announced that they have re-signed right-handed pitcher Bartolo Colón to a one-year contract. Terms of the deal are not yet known for the Wasserman Media Group client.

Colon turned in a 3.43 ERA with 5.4 K/9 and 1.4 BB/9 through 24 starts before a positive test for testosterone landed him a 50-game suspension in August. The 39-year-old still must serve five games of that suspension in 2013.

The right-hander made just 47 starts from 2006-2009 and missed the 2010 season but turned in a strong 2011 for the Yankees. For his career, Colon has a 4.05 ERA with 6.9 K/9 and 2.9 BB/9.

Mike Axisa and Edward Creech contributed to this post.

Bartolo Colon Fails MLB Drug Test

By | at

Bartolo Colon has failed an MLB-issued drug test and has been suspended for 50 games, reports Jon Heyman of CBSSports.com. Both the Athletics and MLB have confirmed the suspension. Tim Brown of Yahoo! Sports says (on Twitter) that he tested positive for testosterone. 

Colon, 39, resurrected his career last season after undergoing an experimental stem cell treatment on his injured shoulder, a procedure MLB investigated last summer. Colon is scheduled to become a free agent after the season.

The veteran right-hander has pitched to a 3.43 ERA with 5.4 K/9 and 1.4 BB/9 in 24 starts and 152 1/3 innings for the Athletics this season after signing a one-year, $2MM contract. After missing all of 2010 and most of the 2006-2009 season, the 2005 AL Cy Young Award winner resurfaced with the Yankees last season and posted a 4.00 ERA in 164 1/3 innings.

Brett Anderson returned to the Athletics' rotation last night, pitching seven innings and allowing one earned run. He projects to join Brandon McCarthy, Tommy Milone and Jarrod Parker in the rotation for the remainder of the season. Dan Straily, Tyson Ross and Travis Blackley are also rotation options for the Athletics, who are deep enough in starting pitching to withstand the loss of Colon.

Orioles Interested In Francisco Liriano

By | at

4:58pm: The Angels and Orioles remain in the mix for Liriano, according to Jon Paul Morosi of FOX Sports (via Twitter).

12:41pm: The Orioles have inquired about Francisco Liriano, Jon Heyman of CBSSports.com reports. Baltimore is looking to acquire a starting pitcher and their chances at a high-end starter such as Zack Greinke aren’t great, so they’re inquiring on other arms. 

Jayson Stark reported yesterday that Liriano is "nearly 100 percent" likely to be traded. The Angels, Red Sox, Yankees, Mets, Blue Jays and Braves are believed to have some interest in Liriano, Heyman reported earlier this month. The 28-year-old left-hander has a 5.31 ERA with 9.8 K/9 and 5.0 BB/9 in 100 innings this year. He earns $5.5MM and is eligible for free agency after the season.

The Orioles have also shown interest in Bartolo Colon, as Ken Rosenthal reported last week. The A’s will likely keep Colon, since he may be worth more on their roster than in a trade, Heyman reports.

Starting Pitching Rumors: Nationals, Greinke, Tigers

By | at

The Nationals, Braves, Tigers and Dodgers are in on Ryan Dempster, who could be traded sooner, rather than later. But what about the rest of the starting pitcher market? Here’s the latest:

  • The Nationals don't intend to trade top prospects for a starting pitcher, ESPN.com's Buster Olney tweets.
  • The Tigers intend to trade for a difference-making starting pitcher, Danny Knobler of CBSSports.com reports (Twitter links). The Rays appear to be telling teams James Shields isn't available yet, Knobler adds.
  • It’s possible that Cole Hamels and Zack Greinke will both remain with their current teams at the trade deadline, and if they stay put demand will increase for the next tier of available starters, Ken Rosenthal of FOX Sports writes. The trade value of pitchers such as Shields and Matt Garza would increase and teams undecided about their midseason plans — the Marlins and Rays, for example — could decide to take advantage of the market and sell.
  • One rival executive said he’s “very” concerned about Greinke given his recent poor performances and potential fatigue issues. Another executive told Rosenthal that Greinke is a scary potential trade target.
  • The Orioles are among the teams that have shown interest in Bartolo Colon, Rosenthal reports.
  • The Tigers are still interested in acquiring a starting pitcher, Jon Paul Morosi of FOX Sports reports (Twitter links). However, they aren’t serious players in the market for Greinke.
  • In today's Insider-only blog post, ESPN's Buster Olney explained that players can improve their trade value by performing well in the days and weeks leading up to the trade deadline. Paul Maholm of the Cubs is one example, and clubs have already shown an interest in him. – Mike Axisa

Brown On Athletics, Dodgers, Brewers

By | at

The Athletics, suddenly in contention with a 46-43 record, are one of the few contenders with potential surplus pitching, Yahoo’s Tim Brown writes. They could use production from the left side of their infield and appear to be interested in trading for upgrades. Here’s the latest from Brown, starting in Oakland…

  • The A’s would likely trade 39-year-old right-hander Bartolo Colon if they deal a starter, Brown writes. However, Ken Rosenthal reported today that a deal involving Colon is highly unlikely.
  • Assistant GM David Forst said the A’s aren’t looking to sacrifice a lot in mid-season trades. "We're listening. But we're not looking to significantly change the composition of this team," Forst told Brown.
  • The Dodgers have found trade discussions slow as they look to add starting pitching and corner infield help.
  • The Brewers appear to be seeking Major League pitching for Aramis Ramirez, Brown writes. Brown reported last week that the Dodgers are eyeing the veteran third baseman.
  • The White Sox, Angels, Rangers, Braves, Orioles, Red Sox, Dodgers, Diamondbacks, Pirates, Cardinals and Tigers are among the teams that are currently seeking starting pitching, Brown writes.

Rosenthal On Rays, Colon, Angels, Dempster

By | at

James Shields isn’t the only member of the Tampa Bay pitching staff who could be traded this summer. The Rays are open to moving any of their right-handed starters, Ken Rosenthal of FOX Sports reports. Right-handers Jeremy Hellickson, Wade Davis, Alex Cobb and Chris Archer would all appeal to teams in need of pitching. Here are more of Rosenthal’s notes from around MLB…

  • The Rays probably won’t sell if it appears Evan Longoria will be able to return before long, but the third baseman’s timeline remains unclear.
  • It’s highly unlikely that the Athletics will trade Bartolo Colon, Rosenthal reports. The A’s value Colon more than the mid-level prospects they’d be able to acquire for him in a trade.
  • Executives say the Angels have enough young talent to trade for a pitcher of Zack Greinke’s caliber. Though GM Jerry Dipoto is reluctant to trade Peter Bourjos and Garrett Richards, both would appeal to other teams. One executive noted that prospects Jean Segura and Kaleb Cowart are also appealing trade chips.
  • The Angels are looking for a left-handed reliever, Rosenthal reports.
  • The Cubs are exchanging names with teams interested in Ryan Dempster. The Dodgers, Tigers, Braves and Red Sox are in the mix. A friend of Dempster’s said the right-hander would probably approve a trade to Boston but considers the Dodgers a better fit. The Dodgers have enough prospects to build a package for Dempster, rival executives tell Rosenthal.
  • The Red Sox are still interested in Matt Garza, another potential trade chip. 
  • The prospect-rich Blue Jays are interested in Justin Upton. GM Alex Anthopoulos is pursuing numerous players and willing to listen on all of his own players, Rosenthal writes. The Pirates have shown considerable interest in Upton, but the Diamondbacks don’t view Pittsburgh as a fit.
  • The Rangers are almost certain to bolster their bench. One option: upgrade over catcher Yorvit Torrealba.
  • It’s not surprising to see the Giants pursuing relief help, Rosenthal writes.
Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top